Invitae Corp. is a company in the U.S. stock market and it is a holding in 39 U.S.-traded ETFs. NVTA has around 14.7M shares in the U.S. ETF market. The largest ETF holder of NVTA is the ARK Innovation ETF (ARKK), with approximately 5.25M shares. Investors may also find of interest that the ETF with the largest allocation to NVTA stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 7.68%. On average, U.S. ETFs allocate 0.52% of NVTA to their portfolios.
Additionally, NVTA is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NVTA as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 17.23%.